A Phase 1, Double-Blind, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RC-01 for Injection in Healthy Adult Subjects

A Phase 1 study of the safety, tolerability and pharmacokinetics of a new antibiotic (RC-01). In Part 1 cohorts of healthy adults will participate in a single dose escalation study of increasing intravenous doses of RC-01. In Part 2 cohorts of healthy adults will participate in a multiple dose escalation study of increasing intravenous doses of RC-01 given either twice daily or three times daily.

开始日期2019-04-14

申办/合作机构

Recida Therapeutics, Inc.初创企业

100 项与 RC-01 相关的临床结果

登录后查看更多信息

100 项与 RC-01 相关的转化医学

登录后查看更多信息

100 项与 RC-01 相关的专利（医药）

登录后查看更多信息

项与 RC-01 相关的文献（医药）

2015-01-01·British Journal of Cancer1区 · 医学

miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop

1区 · 医学

Article

作者: Wang, J ; Liu, M ; Li, X ; Dai, J ; Tang, H ; Deng, H ; Zhang, Y ; Wan, H ; Li, S

BACKGROUNDThe effective mechanisms of microRNAs (miRNAs) functions as oncogenes or tumour suppressors in human hepatocellular carcinoma (HCC) are still obscure. Here, we investigated the function and expression of miR-1228 in HCC.METHODSThe role of miR-1228 in HCC was determined by colony formation, transwell, and nude mice xenograft experiments. miR-1228 target gene were identified by EGFP reporter assays, real-time PCR, and western blot analysis. Dual-luciferase reporter assay and real-time PCR analysis are used to examine the regulation of p53.RESULTSmiR-1228 promoted proliferation and metastasis, and facilitated the transition of cell cycle in hepatoma cells. miR-1228 downregulated p53 expression by binding to its 3'UTR. The ectopic expression of p53 abrogated the phenotypes induced by miR-1228. An inverse correlation existed between miR-1228 and p53 expression in hepatoma tissues compared with the adjacent tissues and three hepatoma cell lines. Moreover, we found that p53 suppressed the expression and promoter activity of miR-1228.CONCLUSIONSmiR-1228 functions as an oncogene by promoting cell cycle progression and cell mobility and negatively regulates the expression of p53. p53 downregulation in turn leads to an increase in miR-1228 expression, thereby forming a positive feedback loop that contributes to cancerogenesis in HCC.

100 项与 RC-01 相关的药物交易

登录后查看更多信息